ARTICLE
Volume 10,Issue 7
3 April 2025
Advances in the Study of Telemedicine in Patients With Schizophrenia
Mingyue Yang ,
Na Gao ,
Xuewei Chen ,
Ying Yang ,
Ying Zhang
Show Less
1
School of Nursing, Hangzhou Normal University, Hangzhou 311121, Zhejiang Province, China,
2
Department of Critical Care Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang Province, China,
JCNR 2025 , 9(3), 231–240;
https://doi.org/10.26689/jcnr.v9i3.10074
© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
This article reviews the concept of telemedicine, as well as the current status of its application in patients with schizophrenia, problems, and suggestions for improvement, with the aim of providing a reference for the application of telemedicine in patients with schizophrenia.
References
Marder SR, Cannon TD, 2019, Schizophrenia. N Engl J Med, 381(18): 1753–1761.
Desai PR, Lawson KA, Barner JC, et al., 2013, Identifying Patient Characteristics Associated With High Schizophrenia-Related Direct Medical Costs in Community-Dwelling Patients. J Manag Care Pharm, 19(6): 468–477.
Jauhar S, Johnstone M, McKenna PJ, 2022, Schizophrenia. Lancet, 399(10323): 473–486.
Hjorthoj C, Sturup AE, McGrath JJ, et al., 2017, Years of Potential Life Lost and Life Expectancy in Schizophrenia: A Systematic Review and Meta-Analysis. Lancet Psychiatry, 4(4): 295–301.
Kahn RS, 2020, On the Origins of Schizophrenia. Am J Psychiatry, 177(4): 291–297.
McCutcheon RA, Reis Marques T, Howes OD, 2020, Schizophrenia—An Overview. JAMA Psychiatry, 77(2): 201–210.
Oxenkrug G, Forester B, 2024, Anthranilic Acid, a GPR109A Agonist, and Schizophrenia. Int J Tryptophan Res, 17: 11786469241239125.
Almond S, Knapp M, Francois C, et al., 2004, Relapse in Schizophrenia: Costs, Clinical Outcomes and Quality of Life. Br J Psychiatry, 184: 346–351.
Barlati S, Nibbio G, Vita A, 2021, Schizophrenia During the COVID-19 Pandemic. Curr Opin Psychiatry, 34(3): 203–210.
Tuckson RV, Edmunds M, Hodgkins ML, 2017, Telehealth. N Engl J Med, 377(16): 1585–1592.
National Nursing Career Development Plan 2021–2025, 2022, Chinese Nursing Management, 22(6): 801–804.
Kasckow J, Felmet K, Appelt C, et al., 2014, Telepsychiatry in the Assessment and Treatment of Schizophrenia. Clin Schizophr Relat Psychoses, 8(1): 21–27.
Sood S, Mbarika V, Jugoo S, et al., 2007, What Is Telemedicine? A Collection of 104 Peer-Reviewed Perspectives and Theoretical Underpinnings. Telemed J E Health, 13(5): 573–590.
Centers for Disease Control and Prevention, 2017, National Center for Health Statistics. U.S. Department of Health and Human Services.
Lawes-Wickwar S, McBain H, Mulligan K, 2018, Application and Effectiveness of Telehealth to Support Severe Mental Illness Management: Systematic Review. JMIR Ment Health, 5(4): e62.
Comendador L, Cebria AI, Sanz A, et al., 2023, Telephone-Delivered Interventions for Suicide Prevention in Schizophrenia and Related Disorders: A Systematic Review. Healthcare (Basel), 11(3), 432.
Santesteban-Echarri O, Piskulic D, Nyman RK, et al., 2020, Telehealth Interventions for Schizophrenia-Spectrum Disorders and Clinical High-Risk for Psychosis Individuals: A Scoping Review. J Telemed Telecare, 26(1–2): 14–20.
OReilly R, Bishop J, Maddox K, et al., 2007, Is Telepsychiatry Equivalent to Face-To-Face Psychiatry? Results From a Randomized Controlled Equivalence Trial. Psychiatr Serv, 58(6): 836–843.
Cairns AJJ, Kelly J, Taylor CDJ, 2023, Assessing the Delivering of iMAgery-Focused Therapy for PSychosis (iMAPS) via Telehealth. Psychol Psychother, 96(3): 678–696.
Sharp IR, Kobak KA, Osman DA, 2011, The Use of Videoconferencing With Patients With Psychosis: A Review of the Literature. Ann Gen Psychiatry, 10(1): 14.
Tian Y, Zhang S, Huang F, et al., 2021, Comparing the Efficacies of Telemedicine and Standard Prenatal Care on Blood Glucose Control in Women With Gestational Diabetes Mellitus: Randomized Controlled Trial. JMIR Mhealth Uhealth, 9(5): e22881.
Li M, Chen Y, Hu X, et al., 2023, The Preferences for Telemedicine and Standard Health Care Services From the Perspective of Patients With Schizophrenia. BMC Psychiatry, 23(1): 361.
Bucci S, Barrowclough C, Ainsworth J, et al., 2018, Actissist: Proof-of-Concept Trial of a Theory-Driven Digital Intervention for Psychosis. Schizophr Bull, 44(5): 1070–1080.
Palmier-Claus JE, Ainsworth J, Machin M, et al., 2012, The Feasibility and Validity of Ambulatory Self-Report of Psychotic Symptoms Using a Smartphone Software Application. BMC Psychiatry, 12: 172.
Lewis S, Ainsworth J, Sanders C, et al., 2020, Smartphone-Enhanced Symptom Management in Psychosis: Open, Randomized Controlled Trial. J Med Internet Res, 22(8): e17019.
Godfrey A, Hetherington V, Shum H, et al., 2018, From A to Z: Wearable Technology Explained. Maturitas, 113: 40–47.
Chong KPL, Guo JZ, Deng X, et al., 2020, Consumer Perceptions of Wearable Technology Devices: Retrospective Review and Analysis. JMIR Mhealth Uhealth, 8(4): e17544.
Cella M, He Z, Killikelly C, et al., 2019, Blending Active and Passive Digital Technology Methods to Improve Symptom Monitoring in Early Psychosis. Early Interv Psychiatry, 13(5): 1271–1275.
Schlier B, Krkovic K, Clamor A, et al., 2019, Autonomic Arousal During Psychosis Spectrum Experiences: Results From a High-Resolution Ambulatory Assessment Study Over the Course of Symptom On- and Offset. Schizophr Res, 212: 163–170.
Cella M, Okruszek L, Lawrence M, et al., 2018, Using Wearable Technology to Detect the Autonomic Signature of Illness Severity in Schizophrenia. Schizophr Res, 195: 537–542.
Firth J, Torous J, 2015, Smartphone Apps for Schizophrenia: A Systematic Review. JMIR Mhealth Uhealth, 3(4): e102.
Krzystanek M, Borkowski M, Skalacka K, et al., 2019, A Telemedicine Platform to Improve Clinical Parameters in Paranoid Schizophrenia Patients: Results of a One-Year Randomized Study. Schizophr Res, 204: 389–396.
Ben-Zeev D, Brenner CJ, Begale M, et al., 2014, Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone Intervention for Schizophrenia. Schizophr Bull, 40(6): 1244–1253.
Macias C, Panch T, Hicks YM, et al., 2015, Using Smartphone Apps to Promote Psychiatric and Physical Well-Being. Psychiatr Q, 86(4): 505–519.
Pratt SI, Bartels SJ, Mueser KT, et al., 2013, Feasibility and Effectiveness of an Automated Telehealth Intervention to Improve Illness Self-Management in People With Serious Psychiatric and Medical Disorders. Psychiatr Rehabil J, 36(4): 297–305.
Higashi K, Medic G, Littlewood KJ, et al., 2013, Medication Adherence in Schizophrenia: Factors Influencing Adherence and Consequences of Nonadherence, A Systematic Literature Review. Ther Adv Psychopharmacol, 3(4): 200–218.
Lacro JP, Dunn LB, Dolder CR, et al., 2002, Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature. J Clin Psychiatry, 63(10): 892–909.
Gray R, Bressington D, Ivanecka A, et al., 2016, Is Adherence Therapy an Effective Adjunct Treatment for Patients With Schizophrenia Spectrum Disorders? A Systematic Review and Meta-Analysis. BMC Psychiatry, 16: 90.
Stentzel U, Van Den Berg N, Schulze LN, et al., 2018, Predictors of Medication Adherence Among Patients With Severe Psychiatric Disorders: Findings From the Baseline Assessment of a Randomized Controlled Trial (Tecla). BMC Psychiatry, 18(1): 155.
Tamene FB, Mihiretie EA, Mulugeta A, et al., 2024, Medication Non-Adherence and Associated Factors Among People With Schizophrenia: Multicenter Cross-Sectional Study in Northwest Ethiopia. BMC Psychiatry, 24(1): 567.
Velligan D, Mintz J, Maples N, et al., 2013, A Randomized Trial Comparing In-Person and Electronic Interventions for Improving Adherence to Oral Medications in Schizophrenia. Schizophr Bull, 39(5): 999–1007.
Huang A, 2022, Influence of Remote Health Management Model on Self-Efficacy and Compliance Behavior of Patients With Schizophrenia in Stable Stage. Chinese Evidence-Based Nursing, 8(6): 785–789.
Sher L, Kahn RS, 2019, Suicide in Schizophrenia: An Educational Overview. Medicina (Kaunas), 55(7), 361.
Flaherty LR, Daniels K, Luther J, et al., 2017, Reduction of Medical Hospitalizations in Veterans With Schizophrenia Using Home Telehealth. Psychiatry Res, 255: 153–155.
Kasckow J, Zickmund S, Gurklis J, et al., 2016, Using Telehealth to Augment an Intensive Case Monitoring Program in Veterans With Schizophrenia and Suicidal Ideation: A Pilot Trial. Psychiatry Res, 239: 111–116.
Kasckow J, Gao S, Hanusa B, et al., 2015, Telehealth Monitoring of Patients With Schizophrenia and Suicidal Ideation. Suicide Life Threat Behav, 45(5): 600–611.
Fleischmann A, Bertolote JM, Wasserman D, et al., 2008, Effectiveness of Brief Intervention and Contact for Suicide Attempters: A Randomized Controlled Trial in Five Countries. Bull World Health Organ, 86(9): 703–709.
Eisner E, Drake R, Barrowclough C, 2013, Assessing Early Signs of Relapse in Psychosis: Review and Future Directions. Clin Psychol Rev, 33(5): 637–653.
Csernansky JG, Schuchart EK, 2002, Relapse and Rehospitalization Rates in Patients With Schizophrenia: Effects of Second-Generation Antipsychotics. CNS Drugs, 16(7): 473–487.
Green MF, Horan WP, Lee J, et al., 2018, Social Disconnection in Schizophrenia and the General Community. Schizophr Bull, 44(2): 242–249.
Torous J, Firth J, Mueller N, et al., 2017, Methodology and Reporting of Mobile Health and Smartphone Application Studies for Schizophrenia. Harv Rev Psychiatry, 25(3): 146–154.
Buck B, Scherer E, Brian R, et al., 2019, Relationships Between Smartphone Social Behavior and Relapse in Schizophrenia: A Preliminary Report. Schizophr Res, 208: 167–172.
Eisner E, Drake RJ, Berry N, et al., 2019, Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse. JMIR Mhealth Uhealth, 7(3): e11568.
Ybarra ML, Rodriguez K, Madison H, et al., 2019, Developing Texting for Relapse Prevention: A Scalable mHealth Program for People With Schizophrenia and Schizoaffective Disorder. J Nerv Ment Dis, 207(10): 854–862.
Ybarra ML, Rodriguez KM, Fehmie DA, et al., 2022, Acceptability of Texting 4 Relapse Prevention, Text Messaging-Based Relapse Prevention Program for People With Schizophrenia and Schizoaffective Disorder. J Nerv Ment Dis, 210(2): 123–128.
Cui F, Ma Q, He X, et al., 2020, Implementation and Application of Telemedicine in China: Cross-Sectional Study. JMIR Mhealth Uhealth, 8(10): e18426.
Lin JC, Kavousi Y, Sullivan B, et al., 2020, Analysis of Outpatient Telemedicine Reimbursement in an Integrated Healthcare System. Ann Vasc Surg, 65: 100–106.
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia